Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 553

Cited In for PubMed (Select 2881207)

1.

Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.

Ksiazek-Winiarek DJ, Szpakowski P, Glabinski A.

Neural Plast. 2015;2015:307175. doi: 10.1155/2015/307175. Epub 2015 Jul 2. Review.

2.

Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease.

Gupta A, Iadecola C.

Front Aging Neurosci. 2015 Jun 16;7:115. doi: 10.3389/fnagi.2015.00115. eCollection 2015. Review.

3.

Biomarkers of postoperative delirium and cognitive dysfunction.

Androsova G, Krause R, Winterer G, Schneider R.

Front Aging Neurosci. 2015 Jun 9;7:112. doi: 10.3389/fnagi.2015.00112. eCollection 2015. Review.

4.

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.

Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG.

Front Cell Neurosci. 2015 May 26;9:191. doi: 10.3389/fncel.2015.00191. eCollection 2015. Review.

5.

Few-layer bismuth selenides exfoliated by hemin inhibit amyloid-β1-42 fibril formation.

Peng J, Xiong Y, Lin Z, Sun L, Weng J.

Sci Rep. 2015 May 28;5:10171. doi: 10.1038/srep10171.

6.

Historic evidence to support a causal relationship between spirochetal infections and Alzheimer's disease.

Miklossy J.

Front Aging Neurosci. 2015 Apr 16;7:46. doi: 10.3389/fnagi.2015.00046. eCollection 2015. Review.

7.

Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's disease.

Dewji NN, Singer SJ, Masliah E, Rockenstein E, Kim M, Harber M, Horwood T.

PLoS One. 2015 Apr 29;10(4):e0122451. doi: 10.1371/journal.pone.0122451. eCollection 2015.

8.

The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.

Rudy CC, Hunsberger HC, Weitzner DS, Reed MN.

Aging Dis. 2015 Mar 10;6(2):131-48. doi: 10.14336/AD.2014.0423. eCollection 2015 Mar. Review.

9.

Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease.

Canobbio I, Abubaker AA, Visconte C, Torti M, Pula G.

Front Cell Neurosci. 2015 Mar 3;9:65. doi: 10.3389/fncel.2015.00065. eCollection 2015. Review.

10.

Cerebrospinal fluid levels of amyloid precursor protein are associated with ventricular size in post-hemorrhagic hydrocephalus of prematurity.

Morales DM, Holubkov R, Inder TE, Ahn HC, Mercer D, Rao R, McAllister JP 2nd, Holtzman DM, Limbrick DD Jr.

PLoS One. 2015 Mar 4;10(3):e0115045. doi: 10.1371/journal.pone.0115045. eCollection 2015.

11.

Axonal Terminals Exposed to Amyloid-β May Not Lead to Pre-Synaptic Axonal Damage.

Sun SW, Nishioka C, Labib W, Liang HF.

J Alzheimers Dis. 2015;45(4):1139-48. doi: 10.3233/JAD-142154.

PMID:
25697704
12.

Automated Classification to Predict the Progression of Alzheimer's Disease Using Whole-Brain Volumetry and DTI.

Jung WB, Lee YM, Kim YH, Mun CW.

Psychiatry Investig. 2015 Jan;12(1):92-102. doi: 10.4306/pi.2015.12.1.92. Epub 2015 Jan 12.

13.

Mulberry extracts alleviate aβ 25-35-induced injury and change the gene expression profile in PC12 cells.

Song N, Yang H, Pang W, Qie Z, Lu H, Tan L, Li H, Sun S, Lian F, Qin C, Jiang Y.

Evid Based Complement Alternat Med. 2014;2014:150617. doi: 10.1155/2014/150617. Epub 2014 Dec 17.

14.

Cycle on Wheels: Is APP Key to the AppBp1 Pathway?

Chen Y, Neve R, Zheng H, Griffin W, Barger S, Mrak R.

Austin Alzheimers Parkinsons Dis. 2014;1(2). pii: id1008.

15.

Preventing Alzheimer's disease by means of natural selection.

Demetrius LA, Driver JA.

J R Soc Interface. 2015 Jan 6;12(102):20140919. Review.

16.

Shedding of APP limits its synaptogenic activity and cell adhesion properties.

Stahl R, Schilling S, Soba P, Rupp C, Hartmann T, Wagner K, Merdes G, Eggert S, Kins S.

Front Cell Neurosci. 2014 Dec 3;8:410. doi: 10.3389/fncel.2014.00410. eCollection 2014.

17.

Differential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning.

Wasser CR, Masiulis I, Durakoglugil MS, Lane-Donovan C, Xian X, Beffert U, Agarwala A, Hammer RE, Herz J.

Sci Signal. 2014 Nov 25;7(353):ra113. doi: 10.1126/scisignal.2005438.

18.

Cholesterol balance in prion diseases and Alzheimer's disease.

Hannaoui S, Shim SY, Cheng YC, Corda E, Gilch S.

Viruses. 2014 Nov 20;6(11):4505-35. doi: 10.3390/v6114505.

19.

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.

Tu S, Okamoto S, Lipton SA, Xu H.

Mol Neurodegener. 2014 Nov 14;9:48. doi: 10.1186/1750-1326-9-48. Review.

20.

Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.

Alexander AG, Marfil V, Li C.

Front Genet. 2014 Sep 5;5:279. doi: 10.3389/fgene.2014.00279. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk